Skip to content

Neuroplasticity: all studies

Page 106 of 178: studies 1,051 to 1,060 of 1,773, newest first. Back to the neuroplasticity overview

Research

Pharmacological characterisation of JNJ-78911118, a novel, centrally-penetrant, selective GluN2A antagonist.

British Journal of Pharmacology May 13, 2025 Brian Lord, Sirak Simavorian, Ian Fraser et al. 2 citations

Non-selective NMDA receptor antagonism produces rapid symptom improvement in treatment-resistant depression; however, associated side effects necessitate medical oversight during administration. We hypothesised that selective GluN2A antagonism could provide similar efficacy with an improved side effect profile. Here, we report the pharmacology of JNJ-78911118, a brain-penetrant, GluN2A...

Synergistic modulation of gut microbiota and mindfulness-based interventions in schizophrenia: Integrating neurotransmitter regulation and multimodal therapeutic strategies

Quality in Sport May 12, 2025 Izabela Zajkowska, Patrycja Niczyporuk, Aleksandra Giba et al. 1 citation

This review explores an innovative, integrative therapeutic approach that combines probiotics, prebiotics, and mindfulness-based interventions (MBIs) to target the dysregulation of the gut–brain axis in schizophrenia. The rationale for this combined strategy is rooted in the overlapping mechanisms by which both biological and psychosocial interventions influence neurophysiological processes....

DOI: 10.12775/qs.2025.41.59834 (opens in new tab) Mindfulness Schizophrenia object-oriented programming Multimodal therapy Psychological intervention +6

Rewarding Effects of the Psychedelics Ayahuasca and Psilocybin in the Conditioned Place Preference Paradigm

Digital Library of Theses and Dissertations (Universidade de São Paulo) May 12, 2025 Vítor Bruno

A presente tese foi dividia em dois capítulos. Capítulo I. Esse capítulo tem como objetivo investigar o possível potencial de reforço induzido pela ayahuasca por meio do paradigma de preferência condicionada por lugar (conditioned place preference, CPP), bem como avaliar se a ayahuasca é capaz de modular a CPP induzida pela cocaína durante as fases de aquisição, expressão e reinstalação da CPP...

Vigilance state dissociation induced by 5-MeO DMT in mice

Research Square May 6, 2025 Benjamin J. B. Bréant, José Prius-Mengual, Alexander Andrews et al. preprint

Abstract Psychedelics lead to profound changes in subjective experience and behaviour, which are typically conceptualised in psychological terms rather than corresponding to an altered brain state or a distinct state of arousal. Here, we performed chronic electrophysiological recordings from the neocortex concomitant with pupillometry in freely moving adult male mice following an injection of a...

DOI: 10.21203/rs.3.rs-6377546/v1 (opens in new tab) Psychedelics Consciousness Sleep research Brain activity

Robot-assisted gait training for individuals with severe acquired brain injury: a scoping review.

Brain Injury May 5, 2025 Vibeke Wagner, Jakob Rud Sørensen, Christina Kruuse et al. 3 citations

Early out-of-bed mobilization is recommended for individuals with severe acquired brain injury and impaired consciousness to promote recovery. Robot-assisted gait training (RAGT) utilizes robotic assistance to facilitate neuroplastic changes through repetitive training and feedback. We aimed to map the evidence of RAGT in non-ambulatory individuals with impaired consciousness or cognitive...

DOI: 10.1080/02699052.2025.2490285 (opens in new tab) Full text (opens in new tab) Brain injury Disorders of consciousness Rehabilitation technologies Robot-assisted gait training +6

Evaluating the Effectiveness of Psychedelic-Assisted Therapy in Treating Alcohol Use Disorders: A Review

Alcoholism Treatment Quarterly May 2, 2025 Ritika Shah, Ashish Sarangi

ABSTRACT Background Alcohol Use Disorder (AUD) is a widespread condition with serious health, social, and economic impacts, often marked by relapse despite the availability of FDA-approved treatments. Recent studies suggest that psychedelic substances, such as psilocybin, Lysergic acid diethylamide (LSD), ayahuasca, etc. may offer novel therapeutic potential in treating AUD by modulating...

Treatment-resistant depression and intranasal esketamine: Spanish clinical consensus on practical aspects

The European Journal of Psychiatry May 2, 2025 Josep Antoni Ramos‐quiroga, Fernando Mora, Silvia Arostegui et al. 4 citations

Pharmacological management of major depressive disorder has traditionally relied on antidepressants targeting the monoaminergic pathway. Treatment-resistant depression (TRD) patients have been frequently excluded from registrational trials, resulting in a lack of clear clinical recommendations for an optimised management. In recent years, treatments based on other mechanisms of action have been...

Psilocybin

May 1, 2025 Jessi Humphreys, Lou Lukas, Yvan Beaussant et al.

Abstract Psilocybin, a naturally occurring psychoactive compound found in more than 200 mushroom species, has an enduring history of use in sacred rituals of Indigenous healers worldwide. With selective serotonin receptor binding, activation of the serotonergic neurological system enables psilocybin to potentiate neuroplasticity, enabling individuals to engage in meaning-making from psychedelic...

Esketamine alleviates cognitive impairment signs induced by modified electroconvulsive therapy in a depression rat model via the KLF4/p38 MAPK pathway.

Journal of Affective Disorders May 1, 2025 Xiaohui Zhou, Li Zhang, Weiwei Gao et al. 4 citations

Depression is a common and serious psychiatric disorder with significant impacts on individuals. Modified electroconvulsive therapy (MECT) is an established treatment for severe and treatment-resistant depression, but its cognitive side effects, particularly memory impairments, limit its use. Esketamine (ESK), an FDA-approved antidepressant, has shown neuroprotective effects. However, its role...

DOI: 10.1016/j.jad.2025.02.012 (opens in new tab) Full text (opens in new tab) Cognitive impairment Modified electroconvulsive therapy Neuroprotection Depression treatment +2

[Suicidal ideation and behaviors: a transdiagnostic dimension for precision psychiatry].

Medecine sciences : M/S May 1, 2025 Aiste Lengvenyte, Emilie Olié, Marion Leboyer et al.

Suicidal thoughts and behaviors represent a transdiagnostic dimension independent of traditional psychiatric diagnoses. This specificity is supported by genetic studies, biomarkers, and preclinical research on endophenotypes associated with suicidal behaviors, such as impulsivity, anhedonia, and hopelessness. Clear mechanisms involving inflammation, the stress response, the serotonergic system,...

DOI: 10.1051/medsci/2025066 (opens in new tab) Full text (opens in new tab) Suicide-research Neurobiology-mental-health Biomarkers-medicine Personalized-psychiatry +1